Trial Disapproval Sample Clauses

Trial Disapproval. If, through no fault of Institution or Principal Investigator, the Trial is disapproved by the IEC, this Agreement will immediately terminate with no penalty to the Institution or Principal Investigator, as outlined below.
Sample 1Sample 2Sample 3See All (16)
AutoNDA by SimpleDocs
Trial Disapproval. If, through no fault of Institution, the Trial is disapproved by the IEC, this Agreement will immediately terminate with no penalty to the Institution, as outlined below. Neschválení hodnocení. Pokud hodnocení nebude nezávislou EK schváleno, a to bez zavinění instituce, platnost této smlouvy bude okamžitě ukončena bez jakýchkoli sankcí pro instituci, jak je uvedeno dále.
Sample 1
Trial Disapproval. If, through no fault of Institution or Principal Investigator, the Trial is disapproved by the IEC, this Agreement will immediately terminate with no penalty to the Institution or Principal Investigator, as outlined below. Zamítnutí klinického hodnocení Bude-li klinické hodnocení bez zavinění zdravotnického zařízení nebo hlavního zkoušejícího zamítnuto ze strany NEK, tato smlouva bude s okamžitou platností ukončena bez sankce pro zdravotnické zařízení nebo hlavního zkoušejícího, jak je popsáno níže. Trial Conduct. Institution and Principal Investigator will conduct the Trial in accordance with the Protocol, Sponsor’s or its designee’s written instructions and Applicable Law. Provádění klinického hodnocení Zdravotnické zařízení a hlavní zkoušející provedou klinické hodnocení v souladu s protokolem, písemnými pokyny zadavatele nebo osoby jím určené a platnými zákony. Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”). For the avoidance of doubt Sponsor will not provide any Sponsor Drug following completion of the Trial. Hodnocený léčivý přípravek Zadavatel poskytne zdravotnickému zařízení dostatečné množství hodnoceného léčivého přípravku (dále jen „hodnocený léčivý přípravek“) k provedení klinického hodnocení. Pokud to požaduje protokol a pokud není dohodnuto jinak, zadavatel rovněž zdarma poskytne placebo nebo srovnávací lék (dále jen „srovnávací lék“). Pro vyloučení pochybností zadavatel neposkytne žádný další hodnocený léčivý přípravek po dokončení klinického hodnocení. Custody and Dispensing. Institution and Principal Investigator will adhere to Applicable Law and industry standards requiring careful custody and dispensing of Sponsor Drug or Comparator Drug, as well as appropriate documentation of such activities. Uchovávání a vydávání léku Zdravotnické zařízení a hlavní zkoušející musí dodržovat platné zákony a odvětvové normy vyžadující pečlivé uchovávání a vydávání hodnoceného léčivého přípravku nebo srovnávacího léku, včetně patřičné dokumentace těchto činností. Control. Institution and Principal Investigator will maintain appropriate control of supplies of Sponsor Drug or Comparator Drug and will not administer or dispense it to anyone who is not a Trial Subject, or provide access to it to anyone except subinvestiga...
Sample 1
Trial Disapproval. If the Trial is disapproved by the IEC or the IEC withdraw its approval, this Agreement will immediately terminate as outlined below.
Sample 1
Trial Disapproval. If, through no fault of Institution or Principal Investigator, the Trial is disapproved by the IEC, this Agreement will immediately terminate with no penalty to the Institution or Principal Investigator, as outlined below. 3.1 Zamítnutí klinického hodnocení Bude-li klinické hodnocení bez zavinění zdravotnického zařízení nebo hlavního zkoušejícího zamítnuto ze strany NEK, tato smlouva bude s okamžitou platností ukončena bez sankce pro zdravotnické zařízení nebo hlavního zkoušejícího, jak je popsáno níže.
Sample 1
Trial Disapproval. If the Trial is disapproved by the IEC, this Agreement will immediately terminate. 3. Nesouhlas s hodnocením. Jestliže nezávislá etická komise neschválí dané hodnocení, bude tato smlouva okamžitě ukončena. 4.
Sample 1
Trial Disapproval. If, through no fault of Healthcare Provider, the Trial is disapproved by the EC, this Agreement will immediately terminate with no penalty to the Healthcare Provider, as outlined below.
Sample 1
AutoNDA by SimpleDocs

Related to Trial Disapproval

  • MOTION FOR FINAL APPROVAL Not later than 16 court days before the calendared Final Approval Hearing, Plaintiff will file in Court, a motion for final approval of the Settlement that includes a request for approval of the PAGA settlement under Labor Code section 2699, subd. (l), a Proposed Final Approval Order and a proposed Judgment (collectively “Motion for Final Approval”). Plaintiff shall provide drafts of these documents to Defense Counsel not later than seven days prior to filing the Motion for Final Approval. Class Counsel and Defense Counsel will expeditiously meet and confer in person or by telephone, and in good faith, to resolve any disagreements concerning the Motion for Final Approval.

  • Final Approval After Acceptance, Engineer shall perform any required modifications, changes, alterations, corrections, redesigns, and additional work necessary to receive Final Approval by the County. "Final Approval" in this sense shall mean formal recognition that the Engineering Services have been fully carried out.

  • Final Approval Hearing “Final Approval Hearing” shall mean the hearing at which the Court will consider and finally decide whether to enter the Final Judgment.

  • License Termination Customer may terminate the license for an ICA Program at any time on one month's written notice to IBM. For ICA Program licenses that Customer acquired for a one-time charge, replacement licenses may be acquired for an upgrade charge, if available. When Customer obtains licenses for these replacement ICA Programs, Customer agrees to terminate the license of the replaced ICA Programs when charges become due, unless IBM specifies otherwise. IBM may terminate Customer’s license if Customer fails to comply with the license terms. If IBM does so, Customer’s authorization to use the ICA Program is also terminated.

  • Notice of Material Events The Borrower will notify the Administrative Agent, for distribution to the LC Issuer and each Lender, promptly, and not later than five (5) Business Days in the case of subsection (b) below and not later than ten (10) Business Days in the case of any other subsection below, after any Responsible Officer or general counsel of the Borrower has knowledge thereof, stating that such notice is being given pursuant to this Agreement, of: (a) the occurrence of any event or circumstance that has had, or could reasonably be expected to have, a Material Adverse Effect, (b) the occurrence of any Default, (c) the acceleration of the maturity of any Indebtedness owed by the Borrower or any of its Subsidiaries or of any default by the Borrower or any of its Subsidiaries under any Contractual Obligation of the Borrower or such Subsidiary, if such acceleration or default has had or could reasonably be expected to have a Material Adverse Effect, (d) the occurrence of any Termination Event, (e) the filing of any suit or proceeding, or the assertion in writing of a claim against the Borrower or any Material Subsidiary or with respect to the Borrower’s or any Material Subsidiary’s properties which could reasonably be expected to result in liability to Borrower or such Material Subsidiary in excess of $50,000,000; (f) the occurrence of any event of default by the Borrower or any of its Subsidiaries in the payment or performance of (i) any material obligations such Person is required to pay or perform under the terms of any indenture, mortgage, deed of trust, security agreement, lease, and franchise, or other agreement, contract or other instrument or obligation to which it is a party or by which it or any of its properties is bound, or (ii) any Indebtedness, to the extent, in the case of clauses (i) and (ii), such event of default could reasonably be expected to have a Material Adverse Effect; and (g) any announcement of any change in a Rating. Each notice pursuant to this Section shall be accompanied by a statement of a Responsible Officer of the Borrower setting forth details of the occurrence referred to herein and stating what action the Borrower, Subsidiary or Material Subsidiary, as applicable, has taken and proposes to take with respect thereto. Each notice pursuant to Section 6.03(b) shall describe with particularity any all provisions of this Agreement and if, applicable, other Loan Documents, that have been breached.

  • Independence from Material Breach Determination Except as set forth in Section X.D.1.c, these provisions for payment of Stipulated Penalties shall not affect or otherwise set a standard for OIG’s decision that Xxxxx has materially breached this IA, which decision shall be made at OIG’s discretion and shall be governed by the provisions in Section X.D, below.

  • Application for approval 3.1. The application for approval of a vehicle type with regard to the AEBS shall be submitted by the vehicle manufacturer or by his authorised representative. 3.2. It shall be accompanied by the documents mentioned below in triplicate: 3.2.1. A description of the vehicle type with regard to the items mentioned in paragraph 2.4., together with a documentation package which gives access to the basic design of the AEBS and the means by which it is linked to other vehicle systems or by which it directly controls output variables. The numbers and/or symbols identifying the vehicle type shall be specified. 3.3. A vehicle representative of the vehicle type to be approved shall be submitted to the Technical Service conducting the approval tests.

  • IRS Plan Approval Articles I through VIII of the agreement used to establish this Xxxx XXX have been approved by the IRS. The IRS approval is a determination only as to form. It is not an endorsement of the plan in operation or of the investments offered.

  • New Project Approval Consultant and District recognize that Consultant’s Services may include working on various projects for District. Consultant shall obtain the approval of District prior to the commencement of a new project.

  • Project Approval The County may issue a Job Order Authorization for the Work, to include the firm-fixed-price of the Job Order and the project duration. Contractor agrees that all clauses of this Contract are applicable to any Job Order issued hereunder. The County reserves the right to reject a Contractor’s Quote based on unjustifiable quantities and/or methods, performance periods, inadequate documentation, or other inconsistencies or deficiencies on the Contractor’s part in the sole opinion of the County. The County reserves the right to issue a unilateral Job Order authorization for the Work if a Quote price cannot be mutually agreed upon. This is based upon unjustifiable quantities in the sole opinion of the County. The County also reserves the right to not issue a Job Order Authorization if the County’s requirement is no longer valid or the project is not funded. In these instances, the Contractor has no right of claim to recover Quote expenses. The County may pursue continuing valid requirements by other means where Contract was not reached with the Contractor.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!